Clinical Trial Update: Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating propranolol to reduce traumatic memory reconsolidation for treating post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Post-traumatic Stress Disorder | Phase 2 | Status: COMPLETED